NHLBI
Research and Policy Update
Number 22
October 2005
This electronic
distribution list will provide updates from the NHLBI Web Site for
the research community. The updates will be sent as needed, but no more
than once a week.
Special September/October Supplements
Supplement
I: NIH Grant Applications—Conversion to an Electronic Submission
Process
Supplement II: Reducing Regulatory Burdens Associated with Health Care
and Research
Funding Updates
Please
Note: Links to RFAs, PAs, and Guide Notices will take
you to the NIH Web site
RFAs
RFA-DK-05-015:
Small Business Technology Transfer to Develop New Therapeutics and Monitoring
Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
Receipt
Dates: |
Letter
of Intent, February 15, 2006 |
Application,
March 15, 2006 |
RFA-DK-05-016:
Small Business Innovation Research to Develop New Therapeutics
and Monitoring Technologies for Type 1 Diabetes (T1D) and
its Complications (SBIR [R43/R44])
Receipt
Dates: |
Letter
of Intent, February 15, 2006 |
Application,
March 15, 2006 |
Cardiovascular
Cell Therapy Research Network Initiative (RFA-HL-06-001), Frequently Asked
Questions
RFPs
RFP: NHLBI-HB-06-06: Phase II/III Trial of Sildenafil for Sickle Cell
Disease-Associated Pulmonary Hypertension - Clinical Sites
Receipt
Dates: |
Letter
of Intent, October 26, 2005 |
Application,
November 21, 2005 |
RFP: NHLBI-HB-06-04: Phase II/III Trial of Sildenafil for Sickle Cell
Disease-Associated Pulmonary Hypertension - Data Coordinating Center
Amendment
1
Receipt
Dates: |
Letter
of Intent, October 26, 2005 |
Application,
November 21, 2005 |
RFP - Amendment 1: NHLBI-HC-06-02: Hispanic Community Health Study - Field
Centers
RFP - Amendment 1: NHLBI-HC-06-01: Hispanic Community Health Study - Coordinating
Center
PAs
PA-06-042:
Academic Research Enhancement Award (R15)
PA-06-041:
NIH Support for Conferences and Scientific Meetings (R13/U13)
PAR-06-039:
Dissemination and Implementation Research in Health
PA-06-034:
Development of Diagnostic Screening Test for Salt Sensitivity (STTR
[R41/R42])
PA-06-033:
Development of Diagnostic Screening Test for Salt Sensitivity (SBIR
[R43/R44])
PA-06-035: The Relationship
Between Hypertension and Inflammation
PA-06-013: Manufacturing
Processes of Medical, Dental, and Biological Technologies (SBIR [R43/R44])
PA-06-012:Manufacturing
Processes of Medical, Dental, and Biological Technologies (STTR [R41/R42])
PA-06-011: Integration
of Heterogeneous Data Sources (SBIR [R43/R44])
PA-06-010: Integration
of Heterogeneous Data Sources (STTR [R41/R42])
PA-06-009: Bioengineering
Nanotechnology Initiative - SBIR (R43/R44)
PA-06-008: Bioengineering
Nanotechnology Initiative (STTR [R41/R42])
PA-06-007: Small Business
Technology Transfer Program Parent Announcement (STTR [R41/R42]): Electronic
Submission of Grant Applications through Grants.gov
PA-06-006: Small Business Innovation Research Program Parent Announcement
(SBIR [R43/R44]): Electronic Submission of Grant Applications through
Grants.gov
PA-06-004: Small Business
Technology Transfer to Improve The Chemistry and Targeted Delivery of
RNAi Molecules (STTR [R41/R42]
PA-06-003: Small Business
Innovation Research to Improve The Chemistry and Targeted Delivery of
RNAi Molecules (SBIR [R43/R44]
Guide
Notices
NOT-HL-06-110: Notice of the NHLBI Clinical Hematology Research Career
Development Program NOT-HL-06-107: Notice
of Community-Responsive Interventions to Reduce Cardiovascular Risk in
American Indians and Alaska Natives
Hurricane
Related
NOT-OD-06-009: Effects of Hurricanes Katrina and Rita on IRB Operations
NOT-OD-06-006:
Delays in Grant Application Submission due
to Hurricane Wilma
For
additional initiatives, please visit the following Web page:
NHLBI Grants and Contracts page
Policy Updates
NHLBI
Update: Change in Allowed Direct Costs and Annual Increases for Program
Project Grants
Changes have been made to the policy regarding direct costs and annual
increases. This affects both new and competing renewal applications.
For more information, please see the online policy page: Allowable
Requested Direct Costs for Program Project Grants (Update)
NIH
Public Access Policy
This is a reminder that NIH policy requests and strongly encourages all
NIH-funded investigators to make their peer-reviewed author final manuscripts
available to other researchers and the public immediately after the final
date of journal publication. For more information, please check the NIH
Public Access Policy Web page.
NIH
Grant Application - Conversion to an Electronic Submission Process
For additional
policy documents, please visit Funding /
Award Policy section on the following Web page:
Funding, Training, and Policies
Training Updates
Updated
Guidelines for the Applicant: Research Supplements to Promote Diversity
in Health-Related Research
For more information
on training and career development programs, please visit the following
Web page:
Training and Career Development
Meetings
List
of upcoming meetings
National
Heart, Lung, and Blood Advisory Council, February 1, 2006
For more information,
and the most current list of upcoming meetings, please visit the following
Web page:
Announcements of NHLBI Meetings, Conferences,
and Events
Reports
of past meetings
Working
Group on Cellular and Molecular Mechanisms of Right Heart Failure,
Executive Summary, October 6-7, 2005
Working
Group on Genome Wide Association in NHLBI Cohorts Meeting Summary,
September 12, 2005
Preventing
Weight Gain in Young Adults, NHLBI Working Group Report, August 31, 2005
For more information
on past meetings, please visit the following Web page:
Workshop
and Meeting Summaries,
and Other Scientific Reports
Press Releases
Vast
Majority of Adults at Risk of Becoming Overweight or Obese—Future Burden
of Obesity–Related Conditions Likely to be Substantial, Warn Researchers,
October 3, 2005
For
additional Press Releases, please visit the following Web page:
Current Press Releases
Selected NHLBI Vacancies
The
NHLBI has no vacancies to highlight at this time.
Note: There are often changes and additions, for the most
current information, please visit the NHLBI
Jobs Opportunities page.
Other Items of Interest
New
Limited Access Dataset: The Salmeterol or Corticosteroids (SOCS)
and the Salmeterol with and without Inhaled Corticosteriods (SLIC)
Trials
These two randomized, placebo-controlled, blinded clinical trials
were concurrently managed to determine whether Inhaled Corticosteriod
(ICS) therapy can be reduced or eliminated in patients with persistent
asthma after adding a long-acting Beta 2-agonist to their treatment
regimen. The results indicate that in patients with persistent
asthma suboptimally controlled by triamcinolone therapy alone
but whose asthma symptoms improve after addition of salmeterol,
a substantial reduction (50%) in triamcinolone dose can occur
without a significant loss of asthma control. However, total elimination
of triamcinolone therapy results in a significant deterioration
in asthma control and, therefore, cannot be recommended. (JAMA,
2001;285:2583-2593. JAMA, 2001;285:2594-2603.)
New
Limited Access Dataset: The Hypertension Detection and Follow-up
Program (HDFP).
This program was designed to test the efficacy of antihypertensive
therapy in reducing all-cause mortality in a population-based
study. The systematic effective management of hypertension has
a great potential for reducing mortality for the large numbers
of people with high BP in the population, including those with
mild hypertension.
An
Archive of the current and past issues
is available on the NHLBI Web site.
Two
ways to unsubscribe:
- Send an e-mail message to: LISTSERV@LIST.NIH.GOV
and, in the text of your message (not the subject line), write
(or copy/paste):
SIGNOFF NHLBI-RESEARCH-POLICY-L
- Use the List Web Page
A) select
this link
B) Enter your e-mail address as it appears in the To: field
of the list,
C) Enter your full name, and
D) Select the button, Leave the list.
|